GenoMed4All Consortium and ERN-EuroBloodNet working together!
A comment of the team has been published on Hemasphere.
GenoMed4All consortium is working together with ERN-EuroBloodNet to facilitate personalised medicine in common, rare and ultrarare haematological diseases using the existing infrastructures and initiatives, including powerful High-Performance Computing facilities, hospital registries, data processing tools, and pre-existing-repositories.
GenoMed4All leverages the ERN-EuroBloodNet healthcare information and repositories gathered through the European Rare Blood Disorders Platform (ENROL).
Recently, a comment from the team has been published on Hemasphere about their novel European approach to challenges and opportunities of precision medicine in Sickle Cell Disease motivated by the manuscript on Precision Medicine and Sickle Cell Disease disseminated last august. The published comment:
- Adds some considerations that interfere with the large-scale generation of good-quality data to advance research in SCD.
- Introduce the novel European approach by GenoMed4All Consortium to overcome some of these challenges.
Find the entire comment on the official website of Hemasphere.